Ticker

10x Genomics (NASDAQ: TXG - Get Free Report) and MSP Recovery (NASDAQ: MSPR - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, profitability, valuation and risk. Risk and Volatility 10x Genomics has a beta

SOPHiA GENETICS (NASDAQ: SOPH - Get Free Report) and MSP Recovery (NASDAQ: MSPR - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations. Valuation and Earnings This table compares SOPHiA

MSP Recovery, Inc. (NASDAQ: MSPR - Get Free Report) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totaling 1,568,727 shares, a growth of 231.4% from the November 30th total of 473,363 shares. Based on an average daily volume of 5,215,219 shares, the days-to-cover ratio

MSP Recovery (NASDAQ: MSPR - Get Free Report) and Tivic Health Systems (NASDAQ: TIVC - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, institutional ownership, earnings and dividends. Analyst Recommendations This is a summary

MSP Recovery, Inc. (NASDAQ: MSPR - Get Free Report) dropped 5.8% during mid-day trading on Wednesday. The company traded as low as $0.30 and last traded at $0.3255. Approximately 1,513,731 shares traded hands during mid-day trading, a decline of 78% from the average daily volume of 6,803,912 shares. The stock had previously closed at $0.3456.